Minerva Neurosciences
NERV
NERV
80 hedge funds and large institutions have $103M invested in Minerva Neurosciences in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less call options, than puts
Call options by funds: $3.4M | Put options by funds: $5.69M
47% less capital invested
Capital invested by funds: $192M → $103M (-$89.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
80
Holding in Top 10
–
Calls
$3.4M
Puts
$5.69M
Top Buyers
| 1 | +$5.41M | |
| 2 | +$2.62M | |
| 3 | +$2.35M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.51M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$935K |
Top Sellers
| 1 | -$7.23M | |
| 2 | -$5.78M | |
| 3 | -$4.56M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$4.14M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.71M |